SLDB logo

Solid Biosciences (SLDB) Cash From Investing

Annual CFI

$9.69 M
-$49.47 M-83.62%

December 31, 2023

Summary

Performance

1-Year Change

-83.62%

3-Year Change

+46.8%

5-Year Change

+136.2%

15-Year Change

-7.26%

SLDB Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.3%
SLDB annual cash flow from investing activities is higher than 77.3% of companies in Healthcare sector

High & Low

All-time High

$59.16 M
SLDB annual cash flow from investing activities is currently -83.62% below its historical high of $59.16 million

3-Year Low

-$91.09 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SLDB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
SLDB next annual earnings announcement is scheduled for Mar 13, 2025

OtherSLDBcash flowmetrics:

Annual CFF

$3.12 M
SLDB annual cash flow from financing activities is $3.12 million

Annual CFO

-$94.18 M
SLDB annual cash flow from operations is -$94.18 million

Annual FCF

-$95.69 M
SLDB annual free cash flow is -$95.69 million

Annual CAPEX

-
SLDB annual capital expenditures value is unknown

Quarterly CFI

-$10.99 M
-$5.81 M-112.27%

September 30, 2024

Summary

Performance

3-Month Change

-112.27%

1-Year Change

-124.26%

3-Year Change

+77.22%

5-Year Change

+77.22%

SLDB Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.51%
SLDB quarterly cash flow from investing activities is higher than 22.51% of companies in Healthcare sector

High & Low

All-time High

$66.10 M
SLDB quarterly cash flow from investing activities is currently -116.62% below its historical high of $66.10 million

3-Year Low

-$59.59 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SLDB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SLDB next earnings announcement is scheduled for Mar 13, 2025

OtherSLDBcash flowmetrics:

Quarterly CFF

$3.26 M
SLDB quarterly cash flow from financing activities is $3.26 million

Quarterly CFO

-$23.71 M
SLDB quarterly cash flow from operations is -$23.71 million

Quarterly FCF

-$23.72 M
SLDB quarterly free cash flow is -$23.72 million

Quarterly CAPEX

-
SLDB quarterly capital expenditures value is unknown

TTM CFI

-$9.36 M
+$13.65 M+59.33%

September 30, 2024

Summary

Performance

3-Month Change

+59.33%

1-Year Change

-196.57%

3-Year Change

-113.36%

5-Year Change

-113.36%

SLDB TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.67%
SLDB TTM cash flow from investing activities is higher than 33.67% of companies in Healthcare sector

High & Low

All-time High

$70.04 M
SLDB TTM cash flow from investing activities is currently -113.36% below its historical high of $70.04 million

3-Year Low

-$91.09 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SLDB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SLDB next earnings announcement is scheduled for Mar 13, 2025

OtherSLDBcash flowmetrics:

TTM CFF

$116.00 M
SLDB TTM cash flow from financing activities is $116.00 million

TTM CFO

-$91.19 M
SLDB TTM cash flow from operations is -$91.19 million

TTM FCF

-$91.73 M
SLDB TTM free cash flow is -$91.73 million

TTM CAPEX

-
SLDB TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SLDB Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-83.6%-124.3%-196.6%
3 y3 years+46.8%+77.2%-113.4%
5 y5 years+136.2%+77.2%-113.4%

SLDB Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-83.6%+110.6%-116.6%+81.6%-113.4%+89.7%
5 y5-year-83.6%+110.6%-116.6%+84.8%-113.4%+92.3%
alltimeall time-83.6%+110.6%-116.6%+84.8%-113.4%+92.3%

Solid Biosciences Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.99 M(+112.3%)
-$9.36 M(-59.3%)
Jun 2024
-
-$5.18 M(-86.6%)
-$23.00 M(-65.2%)
Mar 2024
-
-$38.49 M(-185.0%)
-$66.06 M(-781.8%)
Dec 2023
$9.69 M(-83.6%)
$45.30 M(-283.9%)
$9.69 M(-68.2%)
Sep 2023
-
-$24.64 M(-48.9%)
$30.49 M(-56.5%)
Jun 2023
-
-$48.23 M(-229.4%)
$70.04 M(+19.4%)
Mar 2023
-
$37.26 M(-43.6%)
$58.67 M(-0.8%)
Dec 2022
$59.16 M(-164.9%)
$66.10 M(+343.4%)
$59.16 M(+154.6%)
Sep 2022
-
$14.91 M(-125.0%)
$23.23 M(-136.2%)
Jun 2022
-
-$59.59 M(-257.9%)
-$64.19 M(+20.4%)
Mar 2022
-
$37.74 M(+25.1%)
-$53.31 M(-41.5%)
Dec 2021
-$91.09 M(-1480.1%)
$30.18 M(-141.6%)
-$91.09 M(-24.9%)
Sep 2021
-
-$72.51 M(+48.8%)
-$121.32 M(+148.1%)
Jun 2021
-
-$48.72 M(>+9900.0%)
-$48.89 M(<-9900.0%)
Mar 2021
-
-$35.00 K(-41.7%)
$147.00 K(-97.8%)
Dec 2020
$6.60 M
-$60.00 K(-25.0%)
$6.60 M(-30.6%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$80.00 K(-124.8%)
$9.52 M(-29.8%)
Jun 2020
-
$322.00 K(-95.0%)
$13.56 M(-63.7%)
Mar 2020
-
$6.42 M(+124.8%)
$37.38 M(+52.5%)
Dec 2019
$24.52 M(-191.6%)
$2.85 M(-28.0%)
$24.52 M(+6075.3%)
Sep 2019
-
$3.96 M(-83.6%)
$397.00 K(-108.0%)
Jun 2019
-
$24.14 M(-474.6%)
-$4.96 M(-84.3%)
Mar 2019
-
-$6.45 M(-69.7%)
-$31.60 M(+18.1%)
Dec 2018
-$26.76 M(-356.1%)
-$21.26 M(+1422.1%)
-$26.76 M(+222.2%)
Sep 2018
-
-$1.40 M(-43.9%)
-$8.31 M(-41.6%)
Jun 2018
-
-$2.49 M(+54.6%)
-$14.23 M(-858.7%)
Mar 2018
-
-$1.61 M(-42.6%)
$1.88 M(-82.1%)
Dec 2017
$10.45 M(-357.8%)
-$2.81 M(-61.6%)
$10.45 M(-21.2%)
Sep 2017
-
-$7.32 M(-153.8%)
$13.26 M(-35.6%)
Jun 2017
-
$13.61 M(+95.5%)
$20.57 M(+195.5%)
Mar 2017
-
$6.96 M
$6.96 M
Dec 2016
-$4.05 M(-84.9%)
-
-
Dec 2015
-$26.81 M
-
-

FAQ

  • What is Solid Biosciences annual cash flow from investing activities?
  • What is the all time high annual CFI for Solid Biosciences?
  • What is Solid Biosciences annual CFI year-on-year change?
  • What is Solid Biosciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Solid Biosciences?
  • What is Solid Biosciences quarterly CFI year-on-year change?
  • What is Solid Biosciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Solid Biosciences?
  • What is Solid Biosciences TTM CFI year-on-year change?

What is Solid Biosciences annual cash flow from investing activities?

The current annual CFI of SLDB is $9.69 M

What is the all time high annual CFI for Solid Biosciences?

Solid Biosciences all-time high annual cash flow from investing activities is $59.16 M

What is Solid Biosciences annual CFI year-on-year change?

Over the past year, SLDB annual cash flow from investing activities has changed by -$49.47 M (-83.62%)

What is Solid Biosciences quarterly cash flow from investing activities?

The current quarterly CFI of SLDB is -$10.99 M

What is the all time high quarterly CFI for Solid Biosciences?

Solid Biosciences all-time high quarterly cash flow from investing activities is $66.10 M

What is Solid Biosciences quarterly CFI year-on-year change?

Over the past year, SLDB quarterly cash flow from investing activities has changed by -$56.28 M (-124.26%)

What is Solid Biosciences TTM cash flow from investing activities?

The current TTM CFI of SLDB is -$9.36 M

What is the all time high TTM CFI for Solid Biosciences?

Solid Biosciences all-time high TTM cash flow from investing activities is $70.04 M

What is Solid Biosciences TTM CFI year-on-year change?

Over the past year, SLDB TTM cash flow from investing activities has changed by -$19.05 M (-196.57%)